Opportunities in High Growth Areas within the Life Sciences Space

3min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

Exploring the various sub-sectors within life sciences, including bio-pharma and medical devices, and highlighting attractive investment areas such as immuno-oncology and rare diseases. The chapter also discusses key geographical markets like the United States, UK, and Switzerland.

Expert View Series: Reorg Senior Private Credit Reporter Lucía Camblor speaks to Oaktree’s managing director, Aman Kumar, about direct lending in the life science sector, public-to-private transaction opportunities and Oaktree’s own private credit strategy. If you are not a Reorg subscriber, request access here: https://go.reorg-research.com/Podcast-Trial